Inomata Naoko, Nakamura Kazuko, Yamane Yumiko, Fujita Hiroyuki, Takakura Momoko, Sugawara Mariko, Osuna Hiroyuki, Ikezawa Zenro
Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine.
Arerugi. 2006 Oct;55(10):1304-11.
Aspirin has been known to be an enhancer to wheat allergy, including wheat-dependent, exercise-induced anaphylaxis.
To investigate whether nonsteroidal, anti-inflammatory drugs (NSAIDs) other than aspirin would enhance allergic reactions after wheat ingestion and whether antihistamines and disodium cromoglycate would prevent these reactions.
Seven cases, whose reactions after wheat ingestion were enhanced by aspirin on challenge tests, were enrolled. Skin prick tests (SPT) and CAP-RAST were undergone for wheat and gluten. We used challenge tests of wheat after pretreatment of NSAIDs and preventive drugs.
Four cases were diagnosed with wheat allergy, 3 cases had wheat-dependent, salicylic acid-induced anaphylaxis. SPT and CAP-RAST were positive for wheat and gluten in 5 of 7 cases and 4 of 7 cases, respectively. Dicrofenac enhanced the allergic reactions after wheat ingestion in 1 of 2 cases, whereas etodolac failed to enhance the symptoms in all 5 cases performed. Furthermore, disodium cromoglycate could not completely prevent the allergic reaction in all 4 cases and even enhanced the reaction in 1 case of them. To see an inhibitory effect of antihistamines on the symptoms, fexofenadine (in 2, 1 and 1 case, respectively), olopatadine, and chlorpheniramine were administrated before the challenge test, and as a result these drugs were found to have inhibitory effects on the allergic reaction.
In this study, it was suggested that etodolac might be a relatively safe anti-inflammatory drug on wheat allergy and antihistamines could prevent allergic reactions more than DSCG in patients with wheat allergy.
已知阿司匹林是小麦过敏的增强剂,包括小麦依赖型运动诱发的过敏反应。
研究除阿司匹林外的非甾体抗炎药(NSAIDs)是否会增强摄入小麦后的过敏反应,以及抗组胺药和色甘酸钠是否能预防这些反应。
纳入7例在激发试验中摄入小麦后反应因阿司匹林而增强的患者。对小麦和麸质进行皮肤点刺试验(SPT)和CAP-RAST检测。我们在使用NSAIDs和预防性药物预处理后进行小麦激发试验。
4例被诊断为小麦过敏,3例有小麦依赖型水杨酸诱发的过敏反应。7例中有5例小麦和麸质的SPT及7例中有4例的CAP-RAST呈阳性。双氯芬酸在2例中的1例中增强了摄入小麦后的过敏反应,而依托度酸在所有5例试验中均未增强症状。此外,色甘酸钠在所有4例中均不能完全预防过敏反应,甚至在其中1例中增强了反应。为观察抗组胺药对症状的抑制作用,在激发试验前分别给予非索非那定(分别在2例、1例和1例中使用)、奥洛他定和氯苯那敏,结果发现这些药物对过敏反应有抑制作用。
在本研究中,提示依托度酸可能是一种对小麦过敏相对安全的抗炎药,且抗组胺药比色甘酸钠更能预防小麦过敏患者的过敏反应。